TP53 and cancer: Furthermore, to assess the sensitivity for mutation detection we extended our analysis by including control cfDNA templates with known variant allele frequencies (VAFs) (0.1%, 0.5%, and 1%) for five cancer-associated TP53 mutations (see the ‘Methods’ section for details).